About Captab Biotec Unit II
Captab Biotec Unit II is a company based in Solan (India) founded in 2010 by Kapish Goel, Pawan Goel, and Sushil Goel. It operates as a B2B. Captab Biotec Unit II operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Solan, India
- Founders Kapish Goel, Pawan Goel, Sushil Goel
- SectorsHealthcare
- Email••••••••
- Website captabgroup.com
- Legal Name Captab Biotec Limited
- Date of Incorporation 17 Jan, 2011
- Jurisdiction Baddi, Himachal Pradesh, India
Associated legal entities of Captab Biotec Unit II
Captab Biotec Unit II operates through Captab Biotec Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Captab Biotec Limited CIN U24232HP2011PLC031542 | Strike Off | 17 Jan 2011 | Baddi, Himachal Pradesh | – | – | 6 | View details |
Board of directors of Captab Biotec Limited (Captab Biotec Unit II)
Captab Biotec Limited is the primary company behind Captab Biotec Unit II. The board of Captab Biotec Limited currently have 6 directors; the longest-serving is Rupinder Mayyar, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rupinder Mayyar DIN 03297900 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
| Jagjeet Singh Sodhi DIN 02177116 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
| Tajender Kaur DIN 03232399 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
| Harsimran Kaur Sodhi DIN 02172389 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
| Sumit Mayyar DIN 02972104 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
| Ramandeep Singh DIN 02972113 | Director | 17 Jan 2011 | 15 yrs 8 mo | Captab Biotec Limited |
People of Captab Biotec Unit II
3 people are tracked at Captab Biotec Unit II (3 in leadership).
| Name | Role | Group |
|---|---|---|
Kapish Goel | Co-Founder, CEO | Leadership |
Pawan Goel | Co-Founder | Leadership |
Sushil Goel | Co-Founder | Leadership |
Complete people profiles for Captab Biotec Unit II
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Captab Biotec Unit II
Captab Biotec Unit II operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Captab Biotec Unit II
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Captab Biotec Unit II
The website of Captab Biotec Unit II (captabgroup.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 16.2% vs previous month
Websites whose visitors overlap most with Captab Biotec Unit II. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| addiibiotech.com | 100% | 2K | #8,012,661 | View details | |
| healthbiotech.in | 97% | – | #12,544,949 | View details | |
| alliaancebiotech.com | 89% | – | – | View details |
Similar companies to Captab Biotec Unit II
10 companies that operate in the same segment as Captab Biotec Unit II (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Captab Biotec Unit II
Captab Biotec Unit II was founded in 2010.
Captab Biotec Unit II is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
Kapish Goel is the current CEO of Captab Biotec Unit II. They have also founded this company.
Captab Biotec Unit II manufactures high-quality tablets, capsules, syrups, ointments, and injectables, focusing on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and drug production. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Captab Biotec Unit II's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Captab Biotec Unit II operates through Captab Biotec Limited.
The legal entities of Captab Biotec Unit II currently have 6 directors, including Rupinder Mayyar, Jagjeet Singh Sodhi, Tajender Kaur and others.